Vaccines for Viral Infections in Developing Countries

The purpose of this meeting is to define the problems and explore solutions for delivering viral vaccines to developing countries in Asia. The conference will focus primarily on 5 important diseases: rotavirus, rabies, cervical carcinoma due to human papilloma virus, Japanese encephalitis and influenza. Most vaccine manufacturing capacity is in developed countries such as Japan, Europe and the United States. However, much of the burden of disease is in developing countries where newly developed vaccines for these diseases are not readily available or affordable. The conference will cover the epidemiology and disease burden in less developed countries in Asia, the current status, use and distribution of vaccines for these diseases, the prospect for and problems with developing manufacturing capacity in the 3rd world, and new vaccine technologies on the horizon.

Meeting dates: July 27 - 28, 2006

Location: Yokohama, Japan

Participant List (PDF)

Meeting Agenda (Presentation Material)
The conference includes several sessions and panel discussions over the course of two days and includes personnel from NIAID divisions and NIAID grantees, as well as other scientists from academia and industry from the US and many Asian countries.

Registration and Contact Information
To register for this meeting, please contact:
Teri Greenfield, M.S.
Scientific Program Analyst
Office of Scientific Coordination &
Program Operations, DMID, NIAID, NIH
Bldg. 6610 Rockledge Drive
Room 6060
Bethesda, MD  20892
(Zip for Express Mail ONLY:  20817)
Phone: (301) 496-9977
Fax: (301) 451-1318
tgreenfield@niaid.nih.gov

This meeting is co-sponsored by NIAID, The 21st Century COE Program Hokkaido University’s “Program of Excellence for Zoonosis Control”, and the Gates Foundation.